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Abstract
Background: About half of the daily smokers in Hong Kong have never tried and have no intention to quit
smoking. More than one-third (37.9 %) of daily smokers have attempted to quit but failed. Nicotine replacement
therapy (NRT) is a safe and effective pharmacotherapy to increase abstinence by reducing withdrawal symptoms
during the early stage of smoking abstinence. However, the prevalence of NRT use in Hong Kong is lower than in
most developed countries. The proposed study aims to assess the effectiveness of providing free NRT samples to
smokers on increasing quit attempts and the quit rate.
Methods: Trained university undergraduate students as ambassadors will invite smokers at outdoor public smoking
hotspots to participate in the randomized controlled trial, in which eligible smokers will be randomized to receive a
1-week free NRT sample and medication counselling (intervention) or advice to purchase NRT on their own
(control). The primary outcome is self-reported quit attempts (no smoking for at least 24 hours) in the past 30 days
at 1-month and 3-month telephone follow-up.
Discussion: The findings will inform the effectiveness of delivering free NRT samples at outdoor public smoking
hotspots to increase quit attempts and abstinence. The study will also provide information on smokers’ adherence
to the NRT sample, side effects and safety issues related to the usage. This will improve the design of a large trial to
test the effect of the NRT sample.
Trial registration: ClinicalTrials.gov NCT02491086. Registered on 7 July 2015.
Keywords: Intervention, Nicotine replacement sample, Smoking cessation, Smoking hotspots
Background
Each year over 5000 deaths are attributable to active
smoking in Hong Kong [1]. Quitting smoking is the
most effective preventive medicine to reduce the
burden of many non-communicable diseases. Hong
Kong has the lowest smoking prevalence (10.7 %
daily smokers) in the developed world due to the
strong tobacco measures enacted in the past few
decades [2], but over half (53 %) of daily smokers in
Hong Kong have never tried and have no intention
to quit smoking [3]. More than one-third (37.9 %)
of daily smokers have attempted to quit but failed
[3].
Enforcement of the indoor smoking ban led to in-
creased smoking behaviour in outdoor public areas,
namely smoking hotspots, where an ashtray is available
[4, 5]. These outdoor hotspots were observed in Hong
Kong due to the high population density and relatively
warm weather throughout the year. Nevertheless, the
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increased outdoor smoking allows easier identification
of smokers and makes way for a face-to-face approach
to proactively offer cessation advice outdoors. Since
2009, our research team and the Hong Kong Council
on Smoking and Health have organized the ‘Quit to
Win’ Contest to promote smoking cessation each year
and deliver brief smoking cessation advice for the
smokers at these hotspots. This approach recruited
1003 smokers in 3 months to participate in a random-
ized trial testing the effectiveness of a cash incentive
and a brief smoking cessation intervention, and yielded
a quit rate of 20 % at 6-month follow-up [6] which
warrants development of simple interventions in this
setting.
Nicotine is highly addictive and many smokers are un-
able to quit successfully due to withdrawal symptoms.
Nicotine replacement therapy (NRT) is a safe and effect-
ive pharmacotherapy to reduce these symptoms during
early abstinence and to increase the quit rate in the lon-
ger term [7–9]. In Hong Kong, NRT is included in the
Hospital Authority Drug Formulary, and can be pur-
chased legally over the counter in a pharmacy or pre-
scribed freely from the Tobacco Control Office’s
Quitline and many other smoking cessation clinics.
However, the prevalence of using NRT in Hong Kong is
lower than in most developed countries. In smokers who
had previous quit attempts, 96.8 % tried to quit with
‘self-determination’ and only 23.1 % used prescribed or
over-the-counter medication [3]. On the contrary, the
corresponding percentage of quitting with medication
is at least 40 % in Australia, Canada, the UK, and the
USA [10]. The low prevalence of using NRT in Hong
Kong may be due to the higher price of NRT per day
($5.43 per day) [11] than, say, in the USA (US$2.41–
3.62 per day) [12]. Very few smokers therefore use
NRT for their quit attempts, especially those who do
not prefer to obtain free NRT from the smoking ces-
sation clinics.
The standard duration of using NRT for smoking
cessation is 12 weeks [13, 14]. Providing free NRT for
1 or 2 weeks (i.e. a NRT sample) to motivate smokers
to quit is theoretically based on catastrophic theory,
suggesting that quitters do not necessarily go through
the stages of quitting readiness according to the
transtheoretical model [15], but their quit attempts
can be initiated by various environmental cues such
as sickness [16] and pregnancy [17]. Brief smoking
cessation advice and free medication might stimulate
smokers to start quitting. Two recent US randomized
controlled trials (RCTs) found that a NRT sample in-
creased quitting motivation, confidence and quit at-
tempts in smokers who were not motivated to quit,
compared with those who did not receive the sample
[18, 19].
The NRT sample might also be beneficial for smokers
who have just developed the motivation to quit and will
act soon. The Clinical Practice Guideline for smoking
cessation recommends that clinicians should advise all
smokers to use effective medication for tobacco depend-
ence treatment [13]. Smokers who started to quit shortly
after they decided to quit had a higher likelihood of
achieving long-term abstinence than smokers who had
longer latency between their quitting decision and action
[20–22]. Providing a NRT sample and information on
NRT for these motivated smokers might be a timely
intervention to help them reduce any physical discom-
fort during quitting and hence increase their abstinence.
Misconception about the safety and efficacy of NRT is
associated with a lower interest in using the medication
for quit attempts [23–25]. Nearly half of the smokers
thought that NRT was as dangerous as cigarettes, and
hence underestimated its efficacy to increase quitting suc-
cess [21]. Providing sufficient and scientific information
on NRT is therefore important to enhance the adherence
to the NRT. We also suggest that increasing literacy in
medication, and enhancing smokers’ experience in using
cessation aids are beneficial. Because both abrupt and
gradual cessation with NRT are effective to increase ab-
stinence for motivated and unmotivated smokers [26, 27],
NRT users should be well informed about these ap-
proaches while making their own decisions.
We propose to conduct a RCT to evaluate the effect-
iveness of a NRT sample in adult smokers recruited at
smoking hotspots. The setting for the recruitment and
intervention of the proposed RCT will be similar to the
aforementioned Quit to Win Contest, but we will use a
free NRT sample as the major intervention instead of a
cash incentive. The primary research questions of the
present RCT are: will a NRT sample increase quit at-
tempts and abstinence in smokers who are smoking at
smoking hotspots; and will a NRT sample increase mo-
tivation to quit?
Methods
Trial design
The study aims to motivate smokers to have a quit attempt
with a free NRT sample. We will firstly train nurses and
university undergraduate students as outreach smoking
cessation ambassadors, who will proactively approach the
smokers at outdoor smoking hotspots of urban areas,
where rubbish bins with a collector of cigarette butts are
nearby, and invite them to participate in the two-arm,
parallel-group RCT. The subject recruitment will take
place at nine selected outdoor smoking hotspots where
many smokers will remain and smoke from July 2015 to
January 2016. Informed consent will be obtained from all
participants. The study flow and the schedule of the study
procedures are indicated in Fig. 1 and Table 1, respectively.
Cheung et al. Trials  (2016) 17:355 Page 2 of 8
Our trial design has followed the SPIRIT checklist for
standard protocol items (see Additional file 1).
Subjects
Smokers with the following inclusion criteria will be invited
to participate in our RCT: aged 18 years or older; smoked
10 cigarettes or more per day in the past week; able to read
and speak Chinese; have not used NRT for the past
3 months; have no severe angina and serious cardiac
arrhythmias; have not suffered an acute myocardial event
in the past 4 weeks; and not pregnant and breastfeeding.
Procedures
We will train the smoking cessation ambassadors for the
subject recruitment and delivery of interventions to the
subjects. Recruitment of outreach smoking cessation
ambassadors will be conducted through sending mass
mails to students of the University of Hong Kong.
Fig. 1 Flow of outreach interventions. NRT nicotine replacement therapy
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Retired nurses who are now providing counselling services
in our existing smoking cessation projects will also be re-
cruited. They will be invited to participate in a training
programme about smoking cessation counselling and
pharmacotherapy in assisting smokers to quit smoking.
Our research team (comprised of physicians and nurses)
will develop the training materials and intervention guides
based on the principles of the US Agency for Health Care
Policy and Research (AHCPR) guidelines [28] and the
guidelines of the National Institutes of Health [29] and
World Health Organization [30]. The training content will
cover: the tobacco epidemic in Hong Kong; the health
hazards of smoking; basic skills in assessing smoking de-
pendence and quitting readiness; knowledge of smoking
cessation medication (types of NRT, adherence, side
effects, etc.); and brief counselling skills. At the end of the
training, participants should be capable of delivering a
brief smoking cessation intervention, which includes pro-
viding advice on using NRT.
Smoking cessation ambassadors will be paired up to ap-
proach the smokers and distribute souvenirs at the out-
door smoking hotspots in daytime. The souvenirs will
include a small pack of tissue paper, with motivational
messages (e.g. one in two smokers will be killed by smok-
ing), quitline number (e.g. Quitline of Tobacco Control
Office 1833183) and other resources for smoking cessa-
tion services printed on the tissue-paper pack. If the
smoker is willing to accept the souvenir and talk to the
ambassador, one ambassador will ask further questions
related to eligibility through an informal conversation. If
the subject is eligible, the ambassador will introduce our
RCT and NRT (about its side effects), seek his/her consent
to participate and complete a one-page questionnaire on
his/her behalf. The other ambassador will then randomize
the subject by the sequentially numbered, opaque sealed
envelopes (SNOSE) method.
Interventions
The ambassador will help the subjects in the interven-
tion group decide which type of NRT product (patch or
gum) he/she can use and advise him/her on how to use
the NRT based on his/her smoking habit and daily
cigarette consumption. He/she will also be provided
with an education card about NRT and a 12-page smok-
ing cessation booklet (Fig. 1). Based on the experience
of the previous trials [11, 31, 32], the choice of NRT
(patch or gum) will be made according to the subject’s
preference and the ambassador will provide medication
counselling. Afterwards, the subjects will receive a free
pack of 1-week NRT. If the subject is willing to con-
tinue the counselling at recruitment, the ambassador
will introduce the NRT’s side effects, adherence and
effectiveness (Table 2). Otherwise, the ambassador will
contact the subject to provide such details and enquire
about his/her usage of NRT by telephone within 2 days.
The control group subjects will be given the same
advice on using NRT by the ambassador as the interven-
tion group. The subjects will be suggested to purchase
Table 1 Schedule of enrolment, interventions and assessments
Study period
Enrolment Allocation Post-allocation
Time point Baseline Baseline 1 week 1 month 3 months 6 months
Enrolment
Eligibility screen X
Informed consent X
Allocation X
Interventions
Intervention group X
Control group X
Assessments
Socio-demographic X X
Daily cigarette consumption X X X X X
Intention to quit X X X X X
Self-reported quitting outcomes X X X X
Perceived importance, confidence and difficulty to quit X X X X
Use of NRT X X X X
Biochemically validated quitting outcomes X X X X
NRT nicotine replacement therapy
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NRT on their own, but will not be given the sample.
The same education card and the smoking cessation
booklet will be provided.
Outcomes
The primary outcome is the proportion of any self-
reported quit attempts (no smoking for at least 24 hours)
in the past month at 1-month and 3-month follow-up.
The secondary outcomes are self-reported 7-day point
prevalence of abstinence at 1-month, 3-month and 6-
month follow-up, perceived importance, confidence and
difficulty to quit (scale 0–10) at all follow-up stages, pro-
portion of using NRT in the past week or past month,
and biochemically validated abstinence at 1-month
follow-up.
At 1 week and 1, 3 and 6 months after recruitment, all
subjects will be contacted by a trained interviewer via
telephone for a survey of assessing these outcomes. After
the survey, the interviewer will discuss any difficulties in
quitting and using NRT with the subject. At least seven
call attempts at different time points will be made before
the subject is considered a loss to follow-up. Subjects
who report no smoking in the past 7 days will be consid-
ered self-reported quitters. Self-reported quitters at 1 month
will be invited to participate in a biochemical validation in-
cluding measurement of exhaled carbon monoxide (CO)
and salivary cotinine level by NicAlert® strips (http://
www.nymox.com/default.action?itemid=45) near their resi-
dence. The criteria for validated abstinence were exhaled
CO< 4 ppm and salivary cotinine < 10 ng/ml [33, 34].
Sample size determination
Since the RCT will generate preliminary estimates for
effectiveness of the NRT sample, we propose the sample
size as 50 for each arm (i.e. total sample size = 100). A
similar RCT conducted by Jardin et al. [19] which evalu-
ated the effectiveness of 2-week free NRT to help non-
motivated smokers to quit smoking was used for the
power estimation. The results showed that the 3-month
quit attempt rate of receiving free NRT was significantly
higher than for those who only received a quitline refer-
ral (32 % vs 16 %, p = 0.05). The relative risk (RR) is
therefore determined (32 %/16 % = 2.0). Based on the RR
of 2.0 and the 100 subjects, the power and type I error
for detecting the difference using the Fisher’s exact test
will be 69.7 % and 0.08. Based on our recent experience
with the same recruitment method and setting, the suc-
cessful recruitment rate was about 15.4 % (1254/8063).
We therefore estimate we have to approach 650 smokers
to achieve the target sample size.
Randomization
The individual randomization method by SNOSE will be
used to ensure the allocation sequence is concealed from
both ambassadors and participants before the group al-
location [35, 36]. The primary investigator will prepare
about 150 identical, opaque, sealed, A5-sized envelops,
with a unique three-digit serial number on the cover of
each envelope as an identifier. Half of the envelopes will
each contain an eligibility form, an education card of
NRT and an action plan for the intervention group. The
remaining half will contain the same eligibility form and
education card, and an action plan for the control group.
After inserting the intervention materials in the enve-
lopes, they will be shuffled and then numbered. When
Table 2 Counselling content for the intervention group
Part A: Introduction of NRT
1. Quitting smoking may cause withdrawal symptoms, such as
irritability, insomnia, frustration, anxiety, restlessness and craving
for cigarettes
2. Nicotine gum and patch can help relieve these symptoms
3. Nicotine products are far less dangerous than cigarette smoking
4. Scientific evidence strongly supports that NRT increases the
quit rate and is a safe product.
Part B: Brief instruction for NRT patch
1. Apply patch on clean and dry skin on the chest, back,
upper arms, hips, etc.
2. Apply one patch per day and remove before sleep
3. Change the patch site daily to avoid skin irritation
Part C: Brief instruction for NRT gum
1. Steps of chewing gum: slowly chew the gum 10–15 times
→ the taste gradually becomes stronger→ park the gum in the
buccal area for about 1–2 minutes→ the taste gradually becomes
lighter→ repeat the above steps
2. Avoid soft drinks, coffee and fruit juice 15 minutes before chewing
3. Daily dosage should not be more than 15 pieces
Part D: Detailed instructions on NRT usage
1. Minor side effects may appear such as insomnia, skin irritation,
jaw ache, hiccups and mouth soreness, but they will disappear
after a few days
2. Make using NRT a daily habit
3. The standard medication period is 8 weeks. Suggest
the participants continue medication after using all samples
4. Suggest the participants continue to use patch/gum even
though feeling able to maintain abstinence
5. Must reduce or quit smoking during using patch/gum, otherwise
it will increase the intake of nicotine
6. Tell others that you are using NRT, so that they can remind
you to use it
7. Advise the participant to have healthy food intake and exercise
to prevent weight gain during quitting
8. Our counsellor will call the participants to follow-up the usage
after 1 week
9. Ask the participant to send back unused NRT to us in the
enclosed envelope
10. Call the quitline (1833183) for further enquires
NRT nicotine replacement therapy
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the subject consents to participate, the ambassadors will
open one envelope according to the sequence of the ser-
ial number and assign the treatment condition based on
the action plan.
Allocation concealment
The group allocation will not be known by the subjects and
the ambassador before the assignment allocation. In reality,
smokers often linger and smoke for just about a few mi-
nutes at the hotspots, and then leave. Also, there are far
more smokers than ambassadors in our selected outdoor
hotpots. Therefore, the smokers may not notice the proce-
dures of the enrolment of other subjects clearly. In addition,
not all smokers want to be approached by strangers, and
finally very few of them will agree to participate in the RCT,
which is expected. Therefore, our ambassadors can
rarely approach and recruit a new subject quickly
after finishing the enrolment of a previous subject. It
is unlikely that their decision to join the RCT is
greatly influenced by what they have observed from
others’ enrolment and intervention. Although the
control group subjects may see that other subjects re-
ceive the NRT sample, the impact on the enrolment
and group allocation is limited in reality.
Blinding
Outcome assessors at follow-up will be blinded to the
treatment condition of each participant when they assess
the primary and secondary outcomes, but they may not
be blinded in future follow-up due to disclosure of the
treatment condition by the subject during the interview.
To prevent this, follow-up duties will be done by five
or more interviewers, and follow-up of a particular
subject may be done by different interviewers. The
biochemical validation will be done by a staff member
who has not delivered the intervention and conducted
the telephone follow-up. Yet all subjects will not be
blinded, because they will receive the behavioural
intervention.
Statistical analyses
All data will be entered and analysed by SPSS for Windows
version 20. The rate of quit attempts and 7-day point
prevalence of abstinence will be assessed with the chi-
square test and odds ratios of logistic regression. Con-
tinuous variables of perceived importance, confidence
and difficulty to quit will be tested with repeated-
measures ANOVA. Both intention-to-treat (assuming
missing subjects have no changes) and complete case
analyses will be done.
Data quality control
Either the research nurse, the principal investigator or the
research coordinator will coordinate the fieldwork at each
recruitment site. All of the fieldwork and data manage-
ment will be monitored by the other two co-investigators
(MPW and WHCL). The principal investigator will ran-
domly select five intervention sites by simple individual
randomization for checking of intervention fidelity. The
research assistant and the investigators will have weekly
meetings to review the study progress and procedures and
to discuss any adverse events or dropouts. In view of the
small sample size and short study period, a data monitor-
ing committee, interim analysis and stopping guidelines
will not be necessary. The data collection, management,
analysis, interpretation and production of publications will
be independent from the funding bodies and other com-
peting interests. The trial results will be disseminated via
journal publication and conference presentation, without
exposing the identity of the trial subjects.
Ethics, consent and permissions
The study protocol has been approved by the Institutional
Review Board of the University of Hong Kong/Hospital
Authority Hong Kong West Cluster (IRB reference num-
ber: UW 15-232). Written consent will be sought from all
subjects to participate in this RCT, which will permit the
investigators to disseminate the trial results and the study
protocol via publications, without showing individual
information.
All questionnaires will be stored in a cupboard with
keys kept by the principal investigator and the research
assistant only. The data will be kept for 10 years upon
completion of the study. Electronic datasets of personal
information and contact information will be encrypted
and separated from the research dataset during the study
period, and will be destroyed after the said storage
period.
NRT has been proven an effective and safe aid for
smoking cessation, which can be purchased over the
counter in pharmacies or prescribed freely in smoking
cessation clinics in Hong Kong. A common side effect of
a nicotine patch is skin reaction. About 50 % of patients
using the nicotine patch will experience a local skin
reaction. The reaction is usually mild and self-limiting,
but occasionally worsens over the course of therapy.
Local treatment with hydrocortisone cream (1 %) or
triamcinolone cream (0.5 %) and rotating patch sites
may ameliorate such local reaction. In fewer than 5 % of
patients, such reaction requires the discontinuation of
the NRT. Other side effects are insomnia and/or vivid
dreams. Common side effects of nicotine gum include
mouth soreness, hiccups, dyspepsia and jaw ache. These
effects are generally mild and transient, and can often be
alleviated by correcting the patient’s chewing technique
[13] or correcting the patient’s using habit. All subjects
will be asked at telephone follow-up if they suffer from
these side effects. If so, the counsellor will provide
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counselling on the usage. If the side effects are serious,
the counsellor will ask them to cease usage.
Discussion
Previous studies strongly supported that NRT is a safe
and effective smoking cessation aid for smokers [7–9],
but the low literacy reduces the using prevalence. Des-
pite the widespread promotion of smoking cessation
messages, an increase in the proportion of hardcore
smokers and a reduction in the quit rate support that
more effective methods for promoting cessation aids are
needed [37]. The present RCT will assess whether pro-
viding a NRT sample is an effective health promotion
strategy to enhance more quit attempts and increase ab-
stinence. In addition to the effectiveness in quitting, the
present RCT will yield more information on the adher-
ence to the NRT sample, side effects and safety of NRT
usage, and will also test whether the NRT sample and
counselling increase quit motivation. These findings will
provide insights towards enhancing smoking cessation
services and constructing a larger trial to test the popu-
lation effect in the near future.
A proactive approach with telephone ‘cold-calling’ or
health records has been used by other studies, and was
effective to increase abstinence [38, 39]. The present
study is the first to extend this approach by directly initi-
ating a face-to-face conversation with the smokers and
then providing medication samples at smoking hotspots.
These smokers may be less motivated to quit than those
who seek cessation services through clinics or quitline.
Because unmotivated smokers comprise a large propor-
tion of smokers in Chinese communities, both in the
China mainland and Hong Kong [3, 40], the present
study will increase understanding on how to help these
unmotivated smokers quit.
Trial status
The recruitment is ongoing.
Additional file
Additional file 1: SPIRIT checklist for standard protocol items. (DOC 117 kb)
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